Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Alex Wollet, Julianie De La Cruz Minyety, Elizabeth Vera, Hope Miller, Orieta Celiku +24 more
Driven by 8 papers — median percentile 15. Top paper: “Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma”.
Tricia Kunst, Santhana Webb, Christina DeVisser, Christy Arrowood, Seth M. Steinberg +4 more
Alex Wollet, Julianie De La Cruz Minyety, Elizabeth Vera, Hope Miller, Orieta Celiku +24 more
Tara S. Davis, Kimberly Reinhart, Elizabeth Vera, Alvina Acquaye, Anna Choi +9 more
Elizabeth Vera, Zied Abdullaev, Alvina Acquaye, Kenneth Aldape, Lisa Boris +17 more
Elizabeth Vera, Edina Komlódi-Pásztor, Zied Abdullaev, Anna Choi, Ewa Grajkowska +21 more
Julie A. Hong, Tricia Kunst, Colleen D. Bond, Cara M. Kenney, Cheryl L. Warga +11 more
Tricia Kunst, Jennifer Reyes, Alvina Acquaye-Mallory, Ewa Grajkowska, Byram H. Ozer +11 more
Hope Miller, Elizabeth Vera, Alvina Acquaye, Brayden Chavis, Anna Choi +10 more